Company

PTC Therapeutics, Inc.

Headquarters: South Plainfield, NJ, United States

Employees: 1,167

CEO: Dr. Stuart W. Peltz

NASDAQ: PTCT -1.19%

Market Cap

$2.12 Billion

USD as of Jan. 1, 2024

Market Cap History

PTC Therapeutics, Inc. market capitalization over time

Evolution of PTC Therapeutics, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of PTC Therapeutics, Inc.

Detailed Description

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States, as well as to treat nonsense mutation Duchenne muscular dystrophy in Brazil and Russia; commercializes Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean; and markets Evrysdi for the treatment of spinal muscular atrophy in adults and children two months and older in Brazil. The company's splicing platform includes PTC518, which is being developed for the treatment of Huntington's disease. PTC Therapeutics, Inc. has collaborations with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation to advance drug discovery and development research in regenerative medicine; and Akcea Therapeutics, Inc. to commercialize Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

PTC Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: PTCT wb_incandescent

Stock: FSX: P91 wb_incandescent

Details

Headquarters:

100 Corporate Court

South Plainfield, NJ 07080

United States

Phone: 908 222 7000

Fax: 908 222 7231